Pakistan - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Pakistan Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases rose 3.9% year on year. At 3,925 Cases in 2019, the country was ranked number 17 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. Pakistan is overtaken by Kazakhstan, which was ranked number 16 with 4,930 Cases and is followed by Pakistan with 3,820 Cases. India lead the ranking with 66,255 Cases in 2019, a growth of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 3,925.00 |
| 2018 | 3,716.00 |
| 2017 | 3,475.00 |
| 2016 | 3,331.00 |
| 2015 | 3,059.00 |
How does Pakistan rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 15 |
#15
Kazakhstan
|
5,073 | 2019 | +4.2 % | -2.9 % | View data | |
| 17 |
#17
Pakistan
|
3,925 | 2019 | +5.6 % | +3.9 % | View data | |
| 19 |
#19
Myanmar
|
3,679 | 2019 | +5.2 % | +1.0 % | View data | |